Please ensure Javascript is enabled for purposes of website accessibility
Taylor Carmichael

Taylor Carmichael


Taylor Carmichael is a former attorney and filmmaker. He's the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.

Recent articles


What's the Strongest Buy: Moderna, Teladoc Health, or Fulgent Genetics?

All three of these stocks have had incredible spikes because of COVID-19. One stock, however, is a safer and stronger long-term investment.


1 Green Flag for Fulgent Genetics

Here's why Fulgent stock is running so high.


1 Red Flag for Teladoc Investors

What's the one negative that might keep Teladoc from being a dominant stock?


Could Competitors Threaten Teladoc's Dominance?

Right now Teladoc Health is the dominant name in virtual healthcare. Are there any internet companies that might dislodge Teladoc from its leadership position?


1 Green Flag for Teladoc Health

Here's the main reason you want to own shares of this virtual medical company.


What Are the Risks for Moderna Shareholders?

The biotech has been an incredible stock over the last year. Is it still a buy?


Is There a Future for Moderna Beyond COVID-19?

What does Moderna's future look like aside from its COVID-19 vaccine program?


1 Green Flag for Moderna Stock

Here's a closer look at why you might want to buy the leader in mRNA pharmaceuticals.


4 Reasons I Just Bought This SPAC Stock

Rover has an amazing business model -- it's the Airbnb for dogs.


3 Top Healthcare Stocks to Buy in 2021

Moderna, Teladoc Health, and Fulgent Genetics have all spiked a lot higher because of COVID-19. And all three companies have platforms for growth over the next decade.


Your 2 Best Profit Opportunities in 2021

Infinity Pharmaceuticals is my pick for Stock of the Year. And Shopify is my selection for Stock of the Decade.


3 Green Flags for Novavax Investors, and 1 Red Flag

Since January 2020, Novavax has become 65-bagger. Is it still a buy?

GettyImages-821148970 (1)

Regenerative Tissue Developer Humacyte Going Public Via SPAC

Humacyte is a leader in regenerative medicine, growing human tissue in the lab that can be transplanted into any patient.


Have $3,000? Smart Investors Are Piling Into These 2 Stocks

OptimizeRx and Inari Medical are both crushing the market right now.


eXp World's 2-for-1 Split Takes Effect Today

The online real estate company will begin trading Tuesday at its split-adjusted price -- which looks a lot like its mid-January price. What's next for shareholders?


3 Top E-Commerce Stocks to Buy Now, Farfetch, and eXp World are three e-commerce stocks that will soar in 2021. Here's why.


Is Glu Mobile Stock a Buy?

The stock was up almost 50% in 2020. It's just getting started.


Who Is the Amazon of Real Estate?

Hint: It's not Zillow.


2 Growth Stocks for In-the-Know Investors

Right now, most investors are oblivious to OptimizeRX and eXp World Holdings. Here's why you should know their names.


What's the Upside for Novavax Stock?

Novavax's COVID-19 vaccine could receive emergency use authorizations around the globe. In that case, how much revenue should investors expect?